• Tackling the New Bottleneck of Drug Discovery

  • Sep 12 2024
  • Length: 57 mins
  • Podcast

Tackling the New Bottleneck of Drug Discovery

  • Summary

  • Markus Gershater, chief scientific officer and co-founder of Synthace sits down with Amar Drawid to discuss Synthace’s AI-based platform that enables drug developers to design complex experiments, run them, and capture and analyze the data all in an automated way.

    Show More Show Less
activate_samplebutton_t1

What listeners say about Tackling the New Bottleneck of Drug Discovery

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.